Identification of AB-FUBINACA metabolites in authentic urine samples suitable as urinary markers of drug intake using liquid chromatography quadrupole tandem time of flight mass spectrometry

Drug Testing and Analysis

Volumn 8, Issue 9, 2016, Pages 950-956

  Vikingsson, Svante ^a   Gréen, Henrik ^a,b   Brinkhagen, Linda ^b   Mukhtar, Shahzabe ^a   Josefsson, Martin ^a,b  

^a LINKÖPING UNIVERSITY   (Sweden)

^b DEPARTMENT OF FORENSIC GENETICS AND FORENSIC TOXICOLOGY   (Sweden)

Author keywords

drugs of abuse; human liver microsomes; LC MS MS; metabolites; new psychoactive substances; Spice; synthetic cannabinoids; urine

Indexed keywords

BIOMOLECULES; BODY FLUIDS; COPYRIGHTS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY;

'SPICE'; DRUG OF ABUSE; HUMAN LIVER MICROSOMES; LC-MS-MS; LC.MS/MS; NEW PSYCHOACTIVE SUBSTANCE; PARENT COMPOUNDS; SYNTHETIC CANNABINOID; URINARY MARKERS; URINE;

METABOLITES;

AB-FUBINACA; CANNABINOID; INDAZOLE DERIVATIVE; PSYCHOTROPIC AGENT;

HUMAN; LIQUID CHROMATOGRAPHY; LIVER MICROSOME; METABOLISM; PROCEDURES; SUBSTANCE ABUSE; TANDEM MASS SPECTROMETRY; URINE;

CANNABINOIDS; CHROMATOGRAPHY, LIQUID; HUMANS; INDAZOLES; MICROSOMES, LIVER; PSYCHOTROPIC DRUGS; SUBSTANCE ABUSE DETECTION; TANDEM MASS SPECTROMETRY;

EID: 85028242435     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.1896     Document Type: Article

References (39)

1. K. A. Seely, J. Lapoint, J. H. Moran, L. Fattore. Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2012, 39, 234.
2. M. S. Castaneto, D. A. Gorelick, N. A. Desrosiers, R. L. Hartman, S. Pirard, M. A. Huestis. Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications. Drug Alcohol Depend. 2014, 144, 12.
3. T. Cooks, T. K. Davis, J. Hu, R. Metheny, M. Schwartz, R. Gerona. "Smoking" guns: Answers. Pediatr. Nephrol. 2014. DOI:10.1007/s00467-014-2983-4.
4. A. G. Verstraete. Detection times of drugs of abuse in blood, urine, and oral fluid. Ther. Drug Monit. 2004, 26, 200.
5. M. Hutter, B. Moosmann, S. Kneisel, V. Auwarter. Characteristics of the designer drug and synthetic cannabinoid receptor agonist AM-2201 regarding its chemistry and metabolism. J. Mass Spectrom. 2013, 48, 885.
6. C. L. Moran, V. H. Le, K. C. Chimalakonda, A. L. Smedley, F. D. Lackey, S. N. Owen, P. D. Kennedy, G. W. Endres, F. L. Ciske, J. B. Kramer, A. M. Kornilov, L. D. Bratton, P. J. Dobrowolski, W. D. Wessinger, W. E. Fantegrossi, P. L. Prather, L. P. James, A. Radominska-Pandya, J. H. Moran. Quantitative measurement of JWH-018 and JWH-073 metabolites excreted in human urine. Anal. Chem. 2011, 83, 4228.
7. P. Kavanagh, A. Grigoryev, A. Melnik, S. Savchuk, A. Simonov, V. Rozhanets. Detection and tentative identification of urinary phase I metabolites of phenylacetylindole cannabimimetics JWH-203 and JWH-251, by GC-MS and LC-MS/MS. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2013, 934, 102.
8. P. Adamowicz, D. Zuba, K. Sekula. Analysis of UR-144 and its pyrolysis product in blood and their metabolites in urine. Forensic Sci. Int. 2013, 233, 320.
9. P. Kavanagh, A. Grigoryev, A. Melnik, A. Simonov. The identification of the urinary metabolites of 3-(4-methoxybenzoyl)-1-pentylindole (RCS-4), a novel cannabimimetic, by gas chromatography–mass spectrometry. J. Anal. Toxicol. 2012, 36, 303.
10. A. Grigoryev, S. Savchuk, A. Melnik, N. Moskaleva, J. Dzhurko, M. Ershov, A. Nosyrev, A. Vedenin, B. Izotov, I. Zabirova, V. Rozhanets. Chromatography-mass spectrometry studies on the metabolism of synthetic cannabinoids JWH-018 and JWH-073, psychoactive components of smoking mixtures. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2011, 879, 1126.
11. A. Grigoryev, P. Kavanagh, A. Melnik. The detection of the urinary metabolites of 1-[(5-fluoropentyl)-1H-indol-3-yl]-(2-iodophenyl)methanone (AM-694), a high affinity cannabimimetic, by gas chromatography - mass spectrometry. Drug Test. Anal. 2013, 5, 110.
12. A. Grigoryev, P. Kavanagh, A. Melnik. The detection of the urinary metabolites of 3-[(adamantan-1-yl)carbonyl]-1-pentylindole (AB-001), a novel cannabimimetic, by gas chromatography–mass spectrometry. Drug Test. Anal. 2012, 4, 519.
13. M. Hutter, S. Broecker, S. Kneisel, V. Auwarter. Identification of the major urinary metabolites in man of seven synthetic cannabinoids of the aminoalkylindole type present as adulterants in 'herbal mixtures' using LC-MS/MS techniques. J. Mass Spectrom. 2012, 47, 54.
14. T. Sobolevsky, I. Prasolov, G. Rodchenkov. Detection of JWH-018 metabolites in smoking mixture post-administration urine. Forensic Sci. Int. 2010, 200, 141.
15. M. S. Castaneto, K. B. Scheidweiler, A. Gandhi, A. Wohlfarth, K. L. Klette, T. M. Martin, M. A. Huestis. Quantitative urine confirmatory testing for synthetic cannabinoids in randomly collected urine specimens. Drug Test. Anal. 2015, 7, 483.
16. T. Sobolevsky, I. Prasolov, G. Rodchenkov. Detection of urinary metabolites of AM-2201 and UR-144, two novel synthetic cannabinoids. Drug Test. Anal. 2012, 4, 745.
17. A. Grigoryev, P. Kavanagh, A. Melnik, S. Savchuk, A. Simonov. Gas and liquid chromatography-mass spectrometry detection of the urinary metabolites of UR-144 and its major pyrolysis product. J. Anal. Toxicol. 2013, 37, 265.
18. N. De Brabanter, S. Esposito, E. Tudela, L. Lootens, P. Meuleman, G. Leroux-Roels, K. Deventer, P. Van Eenoo. In vivo and in vitro metabolism of the synthetic cannabinoid JWH-200. Rapid Commun. Mass Spectrom. 2013, 27, 2115.
19. M. A. Elsohly, W. Gul, A. S. Wanas, M. M. Radwan. Synthetic cannabinoids: Analysis and metabolites. Life Sci. 2014, 97, 78.
20. M. J. Jin, J. Lee, M. K. In, H. H. Yoo. Characterization of in vitro metabolites of CP 47,497, a synthetic cannabinoid, in human liver microsomes by LC-MS/MS. J. Forensic Sci. 2013, 58, 195.
21. U. Kim, M. J. Jin, J. Lee, S. B. Han, M. K. In, H. H. Yoo. Tentative identification of phase I metabolites of HU-210, a classical synthetic cannabinoid, by LC-MS/MS. J. Pharm. Biomed. Anal. 2012, 64–65, 26.
22. T. Sobolevsky, I. Prasolov, G. Rodchenkov. Study on the phase I metabolism of novel synthetic cannabinoids, APICA and its fluorinated analogue. Drug Test. Anal. 2015, 7, 131.
23. T. Takayama, M. Suzuki, K. Todoroki, K. Inoue, J. Z. Min, R. Kikura-Hanajiri, Y. Goda, T. Toyo'oka. UPLC/ESI-MS/MS-based determination of metabolism of several new illicit drugs, ADB-FUBINACA, AB-FUBINACA, AB-PINACA, QUPIC, 5F-QUPIC and alpha-PVT, by human liver microsome. Biomed. Chromatogr. 2014, 28, 831.
24. R. Thomsen, L. M. Nielsen, N. B. Holm, H. B. Rasmussen, K. Linnet, the Indices Consortium. Synthetic cannabimimetic agents metabolized by carboxylesterases. Drug Test. Anal. 2014. DOI:10.1002/dta.1731.
25. S. Vikingsson, M. Josefsson, H. Green. Identification of AKB-48 and 5F-AKB-48 Metabolites in authentic human urine samples using human liver microsomes and time of flight mass spectrometry. J. Anal. Toxicol. 2015. DOI:10.1093/jat/bkv045.
26. A.S. Gandhi, A. Wohlfarth, M. Zhu, S. Pang, M. Castaneto, K.B. Scheidweiler, M.A. Huestis. High-resolution mass spectrometric metabolite profiling of a novel synthetic designer drug, N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (STS-135), using cryopreserved human hepatocytes and assessment of metabolic stability with human liver microsomes. Drug Test. Anal. 2014. DO1: 10.1002/dta.1662
27. A. S. Gandhi, M. Zhu, S. Pang, A. Wohlfarth, K. B. Scheidweiler, M. A. Huestis. Metabolite profiling of RCS-4, a novel synthetic cannabinoid designer drug, using human hepatocyte metabolism and TOF-MS. Bioanalysis. 2014, 6, 1471.
28. A. S. Gandhi, M. Zhu, S. Pang, A. Wohlfarth, K. B. Scheidweiler, H. F. Liu, M. A. Huestis. First characterization of AKB-48 metabolism, a novel synthetic cannabinoid, using human hepatocytes and high-resolution mass spectrometry. AAPS J. 2013, 15, 1091.
29. A. Wohlfarth, A. S. Gandhi, S. Pang, M. Zhu, K. B. Scheidweiler, M. A. Huestis. Metabolism of synthetic cannabinoids PB-22 and its 5-fluoro analog, 5F-PB-22, by human hepatocyte incubation and high-resolution mass spectrometry. Anal. Bioanal. Chem. 2014, 406, 1763.
30. A. Wohlfarth, S. Pang, M. Zhu, A. S. Gandhi, K. B. Scheidweiler, M. A. Huestis. Metabolism of RCS-8, a synthetic cannabinoid with cyclohexyl structure, in human hepatocytes by high-resolution MS. Bioanalysis. 2014, 6, 1187.
31. A. Wohlfarth, S. Pang, M. Zhu, A. S. Gandhi, K. B. Scheidweiler, H. F. Liu, M. A. Huestis. First metabolic profile of XLR-11, a novel synthetic cannabinoid, obtained by using human hepatocytes and high-resolution mass spectrometry. Clin. Chem. 2013, 59, 1638.
32. M. Castaneto, A. Wohlfarth, S. Pang, M. Zhu, K. Scheidweiler, R. Kronstrand, M. Huestis. Identification of AB-FUBINACA metabolites in human hepatocytes and urine using high-resolution mass spectrometry. Forensic Toxicol. 2015. DOI:10.1007/s11419-015-0275-8,1.
33. K. C. Chimalakonda, K. A. Seely, S. M. Bratton, L. K. Brents, C. L. Moran, G. W. Endres, L. P. James, P. F. Hollenberg, P. L. Prather, A. Radominska-Pandya, J. H. Moran. Cytochrome P450-mediated oxidative metabolism of abused synthetic cannabinoids found in K2/Spice: identification of novel cannabinoid receptor ligands. Drug Metab. Dispos. 2012, 40, 2174.
34. N. B. Holm, A. J. Pedersen, P. W. Dalsgaard, K. Linnet. Metabolites of 5F-AKB-48, a synthetic cannabinoid receptor agonist, identified in human urine and liver microsomal preparations using liquid chromatography high-resolution mass spectrometry. Drug Test. Anal. 2014. DOI:10.1002/dta.1663.
35. T. Sobolevsky, I. Prasolov, G. Rodchenkov. Detection of urinary metabolites of AM-2201 and UR-144, two novel synthetic cannabinoids. Drug Test. Anal. 2012, 4, 745.
36. A. Wohlfarth, M. S. Castaneto, M. Zhu, S. Pang, K. B. Scheidweiler, R. Kronstrand, M. A. Huestis. Pentylindole/Pentylindazole Synthetic Cannabinoids and Their 5-Fluoro Analogs Produce Different Primary Metabolites: Metabolite Profiling for AB-PINACA and 5F-AB-PINACA. AAPS J. 2015. DOI:10.1208/s12248-015-9721-0.
37. N. Uchiyama, S. Matsuda, M. Kawamura, Y. Shimokawa, R. Kikura-Hanajiri, K. Aritake, Y. Urade, Y. Goda. Characterization of four new designer drugs, 5-chloro-NNEI, NNEI indazole analog, alpha-PHPP and alpha-POP, with 11 newly distributed designer drugs in illegal products. Forensic Sci. Int. 2014, 243, 1.
38. Drug Enforcement Administration, Department of Justice Schedules of controlled substances: temporary placement of four synthetic cannabinoids into Schedule I. Final order. Fed. Regist. 2014, 79, 7577.
39. R. Kronstrand, L. Brinkhagen, C. Birath-Karlsson, M. Roman, M. Josefsson. LC-QTOF-MS as a superior strategy to immunoassay for the comprehensive analysis of synthetic cannabinoids in urine. Anal. Bioanal. Chem. 2014, 406, 3599.